Dr. Kharfan Dabaja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2002
Good Samaritan Hospital of MarylandResidency, Internal Medicine, 1996 - 1999
American University of Beirut Faculty of MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2005 - 2026
IN State Medical License 2001 - 2025
OK State Medical License 2002 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 57 citationsHematopoietic cell transplantation, Version 2.2020Ayman Saad, Marcos de Lima, Sarah Anand, Vijaya Raj Bhatt, Ryan Bookout
Journal of the National Comprehensive Cancer Network. 2020-05-01 - 223 citationsReduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors.Abraham S. Kanate, Alberto Mussetti, Mohamed A. Kharfan-Dabaja, Kwang Woo Ahn, Alyssa DiGilio
Blood. 2016-02-18 - 3 citationsCAR-T cell Therapies for B-cell Lymphoid Malignancies: Identifying Targets Beyond CD19.Yenny M Vanegas, Razan Mohty, Martha E Gadd, Yan Luo, Mahmoud Aljurf
Hematology/oncology and Stem Cell Therapy. 2022-12-15
Abstracts/Posters
- A Phase 2, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Axicabtagene Ciloleucel in Combination with Either Rituximab or Lenalidomide in Patients...Mohamed A Kharfan-Dabaja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Ly...Mohamed A Kharfan-Dabaja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Comparison of Reduced-Intensity Conditioning (RIC) Regimens for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Classical Hodgkin Lymphoma (cHL):a Center f...Mohamed A Kharfan-Dabaja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
Fighting Lymphoma: Treatment Options Include Alternatives to ChemotherapyJune 18th, 2024
Other Languages
- Arabic, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
